Agency: | |
---|---|
State: | Federal |
Type of Government: | Federal |
FSC Category: |
|
NAICS Category: |
|
Posted Date: | Oct 31, 2021 |
Due Date: | |
Bid Source: | Please Login to View Page |
Contact information: | Please Login to View Page |
Bid Documents: | Please Login to View Page |
This is a request for information (RFI) only for the capability of innovative commercial services that support the distribution of USG owned, orally administered, direct-acting antiviral therapeutics that are under an Emergency Use Authorization (EUA) granted by the Food and Drug Administration (FDA) to treat outpatients.
With Free Trial, you can:
You will have a full access to bids, website, and receive daily bid report via email and web.
Follow 66--PANEL,INDICATOR, IN REPAIR/MODIFICATION OF Active Contract Opportunity Notice ID N0010422QUC01 Related Notice
DEPT OF DEFENSE
Bid Due: 5/27/2022
Follow 66--LEAD,TEST Active Contract Opportunity Notice ID SPRMM122QWM12 Related Notice Department/Ind. Agency DEPT
DEPT OF DEFENSE
Bid Due: 5/23/2022
Follow 66--METER,FLOW RATE IND, IN REPAIR/MODIFICATION OF Active Contract Opportunity Notice ID N0010422QSB88
DEPT OF DEFENSE
Bid Due: 6/10/2022
Follow 66--ALTIMETER,ENCODER Active Contract Opportunity Notice ID N0038322QB111 Related Notice Department/Ind. Agency DEPT
DEPT OF DEFENSE
Bid Due: 5/26/2022